PREMIER has several funding opportunities throughout the year. These grants are intended for projects that are translational in nature with studies focused on advancing precision medicine in rheumatology. Projects related to all types of rheumatologic and/or human autoimmune diseases will be considered. Projects should utilize human samples or show direct links to rheumatologic/autoimmune disease in humans.
PREMIER has two funding mechanisms
1. Resource Allocation Program (RAP). We sponsor two different grant mechanisms targeting established ($50,000 maximum) and junior investigators ($40,000 maximum). RAP has two funding cycles per year in the Fall and Spring.
To submit an application go to: https://rapapp.ucsf.edu/
Spring 2023 cycle applications open: Monday, January 23, 2023
Spring 2023 submissions deadline: Monday, February 27, 2023
2. Core Usage Grants. These smaller grants ($1,000-$6,000) are managed directly by PREMIER. They provide funds for investigators’ use of PREMIER Core Services. Projects should seek to advance studies of precision medicine in autoimmune diseases and are encouraged to cultivate new collaborations among investigators. Priority will be given to projects that lead established investigators into new directions, or projects involving new or young investigators in studies of precision medicine in autoimmune disease. There will be two application cycles per year, in June and November.
For grant application instructions: http://premier.ucsf.edu/core-usage-grants
Application Open December 5, 2022
Deadline March 1, 2023, at 5 pm PST
All potential applicants should contact us by filling out a Service Request Form after becoming a PREMIER member [ Join Now ]. Please indicate in your message which grant mechanism you are planning to apply for, so that center personnel can assist with your proposal.
For further questions or comments, please contact [email protected] or 415-502-3558.